Members |
acceptabilityId |
2019-nCoV antigen immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV antigen vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV antigen vaccination not indicated |
Acceptable (foundation metadata concept) |
2019-nCoV antigen vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV antigen vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV detected |
Acceptable (foundation metadata concept) |
2019-nCoV immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV mRNA immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV mRNA vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV mRNA vaccination not indicated |
Acceptable (foundation metadata concept) |
2019-nCoV mRNA vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV mRNA vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV non-replicating viral vector immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV non-replicating viral vector vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV non-replicating viral vector vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV non-replicating viral vector vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV not detected |
Acceptable (foundation metadata concept) |
2019-nCoV recombinant spike protein antigen immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV recombinant spike protein antigen vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV recombinant spike protein antigen vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV recombinant spike protein antigen vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV vaccination not indicated |
Acceptable (foundation metadata concept) |
2019-nCoV vaccination not indicated |
Acceptable (foundation metadata concept) |
2019-nCoV vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV vaccine declined |
Acceptable (foundation metadata concept) |
2019-nCoV virus-like particle antigen immunisation |
Acceptable (foundation metadata concept) |
2019-nCoV virus-like particle antigen vaccination |
Acceptable (foundation metadata concept) |
2019-nCoV virus-like particle antigen vaccine contraindicated |
Acceptable (foundation metadata concept) |
2019-nCoV virus-like particle antigen vaccine declined |
Acceptable (foundation metadata concept) |
201m-Bi |
Acceptable (foundation metadata concept) |
201m-Pb |
Acceptable (foundation metadata concept) |
202-Bi |
Acceptable (foundation metadata concept) |
202-Pb |
Acceptable (foundation metadata concept) |
202-Tl |
Acceptable (foundation metadata concept) |
202m-Pb |
Acceptable (foundation metadata concept) |
203-Bi |
Acceptable (foundation metadata concept) |
203-Hg |
Acceptable (foundation metadata concept) |
203-Pb |
Acceptable (foundation metadata concept) |
203.6 |
Preferred (foundation metadata concept) |
203.6 (qualifier value) |
Preferred (foundation metadata concept) |
204-Bi |
Acceptable (foundation metadata concept) |
204-Tl |
Acceptable (foundation metadata concept) |
204m-Pb |
Acceptable (foundation metadata concept) |
205-Bi |
Acceptable (foundation metadata concept) |
205-Pb |
Acceptable (foundation metadata concept) |
206-Bi |
Acceptable (foundation metadata concept) |
206-Tl |
Acceptable (foundation metadata concept) |
207-Bi |
Acceptable (foundation metadata concept) |
207-Tl |
Acceptable (foundation metadata concept) |
207m-Pb |
Acceptable (foundation metadata concept) |
208-Bi |
Acceptable (foundation metadata concept) |
208-Tl |
Acceptable (foundation metadata concept) |
208.333 |
Preferred (foundation metadata concept) |
208.333 (qualifier value) |
Preferred (foundation metadata concept) |
209-Bi |
Acceptable (foundation metadata concept) |
209-Pb |
Acceptable (foundation metadata concept) |
209-Tl |
Acceptable (foundation metadata concept) |
20G |
Preferred (foundation metadata concept) |
20G (qualifier value) |
Preferred (foundation metadata concept) |
20M post incubation |
Acceptable (foundation metadata concept) |
20alpha-hydroxysteroid dehydrogenase |
Acceptable (foundation metadata concept) |
20p partial trisomy syndrome |
Preferred (foundation metadata concept) |
20p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
20p subtelomeric deletion syndrome |
Acceptable (foundation metadata concept) |
20p12.2 deletion syndrome |
Preferred (foundation metadata concept) |
20p12.2 deletion syndrome (disorder) |
Preferred (foundation metadata concept) |
20p12.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
20p12.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
20p12.3 microdeletion syndrome is a recently described syndrome characterised by Wolff-Parkinson-White syndrome, variable developmental delay and facial dysmorphism. |
Preferred (foundation metadata concept) |
20p13 microdeletion syndrome |
Preferred (foundation metadata concept) |
20p13 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
20q partial trisomy |
Preferred (foundation metadata concept) |
20q partial trisomy (disorder) |
Preferred (foundation metadata concept) |
20q11.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
20q11.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
20q11.2 microduplication syndrome |
Preferred (foundation metadata concept) |
20q11.2 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
20q11.2 microduplication syndrome is a rare chromosomal anomaly syndrome, due to partial duplication of the long arm of chromosome 20, characterised by psychomotor and developmental delay, moderate intellectual disability, metopic ridging/trigonocephaly, short hands and/or feet and distinctive facial features (epicanthus, hypoplastic supraorbital ridges, horizontal/downslanting palpebral fissures, small nose with depressed nasal bridge and anteverted nostrils, prominent cheeks, retrognathia and small, thick ears). Growth delay and cryptorchidism are often associated features. |
Preferred (foundation metadata concept) |
20q13.33 microdeletion syndrome |
Preferred (foundation metadata concept) |
20q13.33 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
21 |
Preferred (foundation metadata concept) |
21 (AJCC) |
Acceptable (foundation metadata concept) |
21 (UICC) |
Acceptable (foundation metadata concept) |
21 (qualifier value) |
Preferred (foundation metadata concept) |
21 DAY FLEA & TICK DIP |
Preferred (foundation metadata concept) |
21 DAY FLEA & TICK DIP (product) |
Preferred (foundation metadata concept) |
21 gene breast recurrence score |
Preferred (foundation metadata concept) |
21 gene breast recurrence score (observable entity) |
Preferred (foundation metadata concept) |
21-Hydroxylase antibody assay |
Acceptable (foundation metadata concept) |
21-Ne |
Acceptable (foundation metadata concept) |
21-deoxycorticosterone |
Preferred (foundation metadata concept) |
21-deoxycorticosterone (substance) |
Preferred (foundation metadata concept) |
21-deoxycortisol |
Preferred (foundation metadata concept) |
21-deoxycortisol (substance) |
Preferred (foundation metadata concept) |
21-hydroxylase |
Acceptable (foundation metadata concept) |
21-hydroxylase antibody |
Acceptable (foundation metadata concept) |
21-hydroxylase deficiency |
Acceptable (foundation metadata concept) |
21-hydroxylase deficiency |
Preferred (foundation metadata concept) |